India-based Freescale Semiconductor and Cactus Semiconductor, a medical application-specific integrated circuit (ASIC) company, have agreed to collaborate to provide customised analogue mixed-signal and system-on-chip (SOC) products to the medical market. The companies have more than 30 years of combined experience in the medical device market and are focused on providing new generations of smaller, lighter, less costly and more efficient medical products.
As part of this collaboration, Freescale will have access to Cactus’s substantial medical applications expertise to aid in the development of customer-specific products. The joint effort also paves the way for future opportunities to expand Freescale’s analogue mixed-signal technology capabilities, helping the company provide a more integrated offering for medical device designers and their customers. Cactus will gain exposure to the medical market through Freescale’s vast network of field sales support.
Freescale and Cactus will initially focus on systems for implantable medical devices, blood glucose monitors and portable medical applications such as blood pressure monitors, electrocardiographs and pulse oximetry devices. The collaboration lays the groundwork for Freescale to work with Cactus to further enhance its catalogue devices by adding custom ASICs and design services to the Freescale portfolio, allowing medical device manufacturers to tailor solutions to meet specific needs.
These capabilities can be leveraged by the growing number of medical device manufacturing facilities in India. Headquartered in Noida, India, Freescale Semiconductors is poised to fuel the country’s surge in medtech-related reverse innovation.
No comments:
Post a Comment